What question did this study set out to answer?

Investigate the interaction between Sp1 and estrogen receptor (ER) proteins in transactivation pathways.

October 1, 1997Molecular EndocrinologyOpen Access

Functional Synergy between the Transcription Factor Sp1 and the Estrogen Receptor

View Full Paper

Ask AI

Bookmark

Authors

Randomized trial examines estrogen-dependent transactivation in ER-negative cells, suggesting new pathways.

Investigate the interaction between Sp1 and estrogen receptor (ER) proteins in transactivation pathways.
Utilized GC-rich oligonucleotides with ERE half-site for promoter-reporter constructs.
Performed gel mobility shift assays and immunoprecipitation studies to analyze protein interactions.
Tested various ER mutants to assess impacts on Sp1-DNA binding and transactivation.
Sp1 and ER proteins physically interact, enhancing Sp1-DNA binding regardless of estrogen presence.
ER mutants lacking specific regions did not enhance transactivation in hormone-independent conditions.
Confirming a novel estrogen-dependent transactivation pathway that operates independently of ERE.

Porter et al. (1997) studied this question.

View Full Paper

Ask AI

Bookmark